These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

169 related articles for article (PubMed ID: 37717562)

  • 21. Hidradenitis Suppurativa in a Large Cohort of Italian Patients: Evaluation of the Burden of Disease.
    Fabbrocini G; Ruina G; Giovanardi G; Dini V; Raone B; Venturini M; Caposiena Caro RD; Veraldi S; Cannavò SP; Merlo G; Bertoldi AM; Fiorentini F; Molinelli E; Atzori L; Bongiorno MR; Lo Re M; Skroza N; Lasagni C; Franchi C; Ardigò M; Di Costanzo L; Stingeni L; Amerio P; Sanna F; Pescitelli L; Broganelli P; De Cupis C; Gualberti G; Saragaglia V; Argenziano G
    Dermatology; 2022; 238(3):487-497. PubMed ID: 34474409
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Screening for Diabetes Mellitus in Patients with Hidradenitis Suppurativa-A Monocentric Study in Germany.
    Abu Rached N; Gambichler T; Ocker L; Dietrich JW; Quast DR; Sieger C; Seifert C; Scheel C; Bechara FG
    Int J Mol Sci; 2023 Apr; 24(7):. PubMed ID: 37047569
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The Effectiveness of Guselkumab in Patients With Hidradenitis Suppurativa Under Clinical Practice Conditions: A Spanish Multicentre Retrospective Study.
    Rivera-Díaz R; Pozo T; Alfageme F; Díaz Ley B; Osorio GF; Chico R; Vilarrasa E; Silvente C; Ciudad Blanco C; Romaní J; Martorell A; Fernández P; Romero Ferreiro C; Molina Leyva A
    Actas Dermosifiliogr; 2023 Oct; 114(9):755-762. PubMed ID: 37331620
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Pain experiences among those living with hidradenitis suppurativa: a qualitative study.
    Orenstein LAV; Salame N; Siira MR; Urbanski M; Flowers NI; Echuri H; Garg A; McKenzie-Brown AM; Curseen KA; Patzer RE; Kavalieratos D; Chen SC
    Br J Dermatol; 2023 Jan; 188(1):41-51. PubMed ID: 36689519
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Clindamycin versus clindamycin plus rifampicin in hidradenitis suppurativa treatment: Clinical and ultrasound observations.
    Caposiena Caro RD; Cannizzaro MV; Botti E; Di Raimondo C; Di Matteo E; Gaziano R; Bianchi L
    J Am Acad Dermatol; 2019 May; 80(5):1314-1321. PubMed ID: 30502416
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Can Ultrasound Examinations Generate Pain in Hidradenitis Suppurativa Patients? Results from a Multicentric Cross-Sectional Study.
    Wortsman X; Reyes-Baraona F; Ramirez-Cornejo C; Ferreira-Wortsman C; Caposiena Caro RD; Molina-Leyva A; Arias-Santiago S; Giavedoni P; Martorell A; Romani J; Gonzalez C; Alfageme F
    Dermatology; 2023; 239(2):277-282. PubMed ID: 36122570
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Disease severity and poor mental health are the main predictors of stigmatization in patients with hidradenitis suppurativa.
    Akoglu G; Yildiz I; Karaismailoğlu E; Esme P
    Dermatol Ther; 2021 May; 34(3):e14910. PubMed ID: 33619860
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Cutaneous body image in patients with hidradenitis suppurativa: a hospital-based cross-sectional study.
    Koumaki D; Rovithi E; Solia Apokidou E; Papadakis M; Katoulis A; Evangelou G
    Sci Rep; 2023 May; 13(1):7898. PubMed ID: 37193758
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Unmet clinical needs and burden of disease in hidradenitis suppurativa: real-world experience from EU5 and US.
    Ingram JR; Bettoli V; Espy JI; Kokolakis G; Martorell A; Villani AP; Wallinger H; Coak E; Kasparek T; Muscianisi E; Richardson C; Kimball AB
    J Eur Acad Dermatol Venereol; 2022 Sep; 36(9):1597-1605. PubMed ID: 35445469
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Baseline Characteristics of a National French E-Cohort of Hidradenitis Suppurativa in ComPaRe and Comparison with Other Large Hidradenitis Suppurativa Cohorts.
    Condamina M; Penso L; Tran VT; Hotz C; Guillem P; Villani AP; Perrot P; Bru MF; Jacquet E; Nassif A; Bachelez H; Wolkenstein P; Beylot-Barry M; Richard MA; Ravaud P; Viguier M; Sbidian E
    Dermatology; 2021; 237(5):748-758. PubMed ID: 33503635
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Itch in Hidradenitis Suppurativa/Acne Inversa: A Systematic Review.
    Agarwal P; Lunge SB; Shetty NS; Karagaiah P; Daveluy S; Ortega-Loayza AG; Tzellos T; Szepietowski JC; Zouboulis CC; Grabbe S; Goldust M
    J Clin Med; 2022 Jun; 11(13):. PubMed ID: 35807098
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Hidradenitis suppurativa in surgeons' practice: Prevalence and treatment approach according to the Hurley stage in Latvia.
    Balcere A; Upeniece I; Snipe K; Jezupovs A
    Dermatol Ther; 2021 Jan; 34(1):e14687. PubMed ID: 33331018
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Inter-rater agreement and reliability of outcome measurement instruments and staging systems used in hidradenitis suppurativa.
    Thorlacius L; Garg A; Riis PT; Nielsen SM; Bettoli V; Ingram JR; Del Marmol V; Matusiak L; Pascual JC; Revuz J; Sartorius K; Tzellos T; van der Zee HH; Zouboulis CC; Saunte DM; Gottlieb AB; Christensen R; Jemec GBE
    Br J Dermatol; 2019 Sep; 181(3):483-491. PubMed ID: 30724351
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Evaluation of Hidradenitis Suppurativa Disease Course During Pregnancy and Postpartum.
    Lyons AB; Peacock A; McKenzie SA; Jacobsen G; Naik HB; Shi VY; Hamzavi IH; Hsiao JL
    JAMA Dermatol; 2020 Jun; 156(6):681-685. PubMed ID: 32347884
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Quality-of-Life Impairment among Patients with Hidradenitis Suppurativa: A Cross-Sectional Study of 1795 Patients.
    Krajewski PK; Matusiak Ł; von Stebut E; Schultheis M; Kirschner U; Nikolakis G; Szepietowski JC
    Life (Basel); 2021 Jan; 11(1):. PubMed ID: 33429896
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Item-specific patterns of the Skindex-17 in individuals with different levels of Hidradenitis Suppurativa severity: a network analysis study.
    Raimondi G; Samela T; Fania L; Abeni D
    Front Public Health; 2023; 11():1284365. PubMed ID: 38026379
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Depression in patients with hidradenitis suppurativa.
    Onderdijk AJ; van der Zee HH; Esmann S; Lophaven S; Dufour DN; Jemec GB; Boer J
    J Eur Acad Dermatol Venereol; 2013 Apr; 27(4):473-8. PubMed ID: 22339940
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Pain management modalities for hidradenitis suppurativa: a patient survey.
    Fernandez JM; Thompson AM; Borgstrom M; Orenstein LAV; Hsiao JL; Shi VY
    J Dermatolog Treat; 2022 May; 33(3):1742-1745. PubMed ID: 32914659
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Pain perception in patients with hidradenitis suppurativa.
    Nielsen RM; Lindsø Andersen P; Sigsgaard V; Theut Riis P; Jemec GB
    Br J Dermatol; 2020 Jan; 182(1):166-174. PubMed ID: 30919930
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Pain and late-onset of hidradenitis suppurativa can have a negative influence on occupational status and educational level. A cross-sectional study.
    Barboza-Guadagnini L; Podlipnik S; Fuertes I; Morgado-Carrasco D; Bassas-Vila J
    Actas Dermosifiliogr; 2023 Jan; 114(1):T1-T8. PubMed ID: 36503621
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.